Brendan B. Springstubb net worth and biography

Brendan Springstubb Biography and Net Worth

Director of Evolent Health

Brendan Springstubb is currently principal of Bedell Canyon LLC, where he provides analysis, engagement strategy, and fundraising assistance to public equity investment firms, with an emphasis on companies in the healthcare sector. Prior to Bedell, Mr. Springstubb was a partner at Engaged Capital, LLC, where he was responsible for sourcing and managing investments primarily in the healthcare industry. Previously, he held multiple roles at Relational Investors, LLC, where he covered the healthcare sector. Mr. Springstubb was previously a member of the SunOpta Inc. Board of Directors, serving as the chair of the Compensation Committee. Mr. Springstubb holds a master’s degree from Johns Hopkins University in biotechnology and a bachelor’s degree in molecular biology and economics from Pomona College. He is a CFA Charterholder and a Certified Financial Risk Manager.

What is Brendan B. Springstubb's net worth?: The estimated net worth of Brendan B. Springstubb is at least $118,183.16 as of March 4th, 2025. Springstubb owns 11,842 shares of Evolent Health stock worth more than $118,183 as of April 7th. This net worth approximation does not reflect any other investments that Springstubb may own. Learn More about Brendan B. Springstubb's net worth.
How do I contact Brendan B. Springstubb?: The corporate mailing address for Springstubb and other Evolent Health executives is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. Evolent Health can also be reached via phone at (571) 389-6000 and via email at investorrelations@evolenthealth.com. Learn More on Brendan B. Springstubb's contact information.
Has Brendan B. Springstubb been buying or selling shares of Evolent Health?: Brendan B. Springstubb has not been actively trading shares of Evolent Health during the past quarter. Most recently, on Tuesday, March 4th, Brendan B. Springstubb bought 5,000 shares of Evolent Health stock. The stock was acquired at an average cost of $8.75 per share, with a total value of $43,750.00. Following the completion of the transaction, the director now directly owns 11,842 shares of the company's stock, valued at $103,617.50. Learn More on Brendan B. Springstubb's trading history.
Who are Evolent Health's active insiders?: Evolent Health's insider roster includes Seth Blackley (Co-Founder, CEO & Director), Mary Duffy (Director), Diane Holder (Director), John Johnson (CFO), Daniel Mccarthy (President), Emily Rafferty (COO), Cheryl Scott (Director), Brendan Springstubb (Director), Steve Tutewohl (COO), Jonathan Weinberg (General Counsel), and Frank Williams (Chairman). Learn More on Evolent Health's active insiders.
Are insiders buying or selling shares of Evolent Health?: In the last year, Evolent Health insiders bought shares 4 times. They purchased a total of 74,000 shares worth more than $666,315.20. In the last year, insiders at the technology company sold shares 5 times. They sold a total of 307,291 shares worth more than $9,290,384.77. The most recent insider tranaction occured on March, 6th when Director Diane Holder bought 2,735 shares worth more than $25,517.55. Insiders at Evolent Health own 1.6% of the company. Learn More about insider trades at Evolent Health.
Information on this page was last updated on 3/6/2025.

Brendan B. Springstubb Insider Trading History at Evolent Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/4/2025	Buy	5,000	$8.75	$43,750.00	11,842

Brendan B. Springstubb Buying and Selling Activity at Evolent Health

Evolent Health Company Overview

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Today's Range

Now: $9.98

$9.34

$10.01

50 Day Range

MA: $9.79

$8.58

$10.71

2 Week Range

Now: $9.98

$8.35

$33.63

Volume

2,972,292 shs

Average Volume

2,237,869 shs

Market Capitalization

$1.16 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2